Breaking News: PPLPHARMA Next 200 Target
ICICI Securities Re-Initiates Coverage on Piramal Pharma with Buy Rating - 22 Dec, 2023. Piramal Pharma Ltd's stock surges over 8% to hit a 52-week high of Rs 140.20 on the BSE after ICICI Securities re-initiated coverage with a buy rating and set a target price of Rs 180.
cup and handle pattern you can see weekly chart why i say 200 targethttps://www.tradingview.com/x/ng1YC5Ac/
cup and handle pattern you can see weekly chart why i say 200 targethttps://www.tradingview.com/x/ng1YC5Ac/
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.